Please enable JavaScript to continue using this application.

Compare $COYA vs $FHTX | Chartloom

Compare

$COYA vs $FHTX

Coya Therapeutics Inc · Foghorn Therapeutics Inc

COYA

Coya Therapeutics Inc

FHTX

Foghorn Therapeutics Inc

Compare $COYA vs $FHTX

Comparing Coya Therapeutics Inc and Foghorn Therapeutics Inc

COYACoya Therapeutics Inc

FHTXFoghorn Therapeutics Inc

COYACoya Therapeutics Inc

Market cap

$116M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

35.49x

Rev growth (TTM)

1793.6%

YTD performance

-12.4%

52W performance

-21.6%

FCF yield

-15.3%

FHTXFoghorn Therapeutics Inc

Market cap

$117M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.04x

Rev growth (TTM)

52.0%

YTD performance

-61.5%

52W performance

-55.6%

FCF yield

-71.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COYA

FHTX

Detailed metrics comparison

COYA

Coya Therapeutics Inc

FHTX

Foghorn Therapeutics Inc

Market Cap

COYA$116M

FHTX$117M

Enterprise Value

COYA$73M

FHTX$49M

Price

COYA$4.95

FHTX$2.00

P/E Ratio

COYAN/A

FHTXN/A

P/S Ratio

COYA14.48x

FHTX3.20x

EV/Sales

COYA9.10x

FHTX1.34x

EV/EBITDA

COYA0.00x

FHTX0.00x

P/B Ratio

COYA2.61x

FHTX1,199.58x

P/FCF Ratio

COYAN/A

FHTXN/A

EV/FCF

COYA-4.10x

FHTX-0.59x

PEG Ratio

COYAN/A

FHTXN/A

Forward P/E (NTM)

COYAN/A

FHTXN/A

Forward P/S (NTM)

COYA35.49x

FHTX4.04x

Revenue (TTM)

COYA$8M

FHTX$37M

Revenue Growth (YoY)

COYA1793.6%

FHTX52.0%

Forward Rev Growth

COYA389.9%

FHTX7.3%

Gross Margin (TTM)

COYA0.0%

FHTX0.0%

Operating Margin (TTM)

COYA0.0%

FHTX0.0%

EBITDA Margin (TTM)

COYA-259.8%

FHTX-180.6%

Net Margin (TTM)

COYA-270.2%

FHTX-175.8%

FCF Margin (TTM)

COYA-221.6%

FHTX-229.4%

Net Income (TTM)

COYA$-22M

FHTX$-65M

FCF (TTM)

COYA$-18M

FHTX$-84M

EPS (TTM)

COYA-$0.92

FHTX-$0.91

ROE (TTM)

COYA-5332.0%

FHTX-30161.0%

ROA (TTM)

COYA-4748.0%

FHTX-3117.0%

ROIC (TTM)

COYA-5332.0%

FHTX-30161.0%

Cash

COYA$43M

FHTX$68M

Debt

COYA$0

FHTX$0

Net Cash/Debt

COYA$43M

FHTX$68M

Current Ratio (TTM)

COYA13.40x

FHTX3.36x

Quick Ratio (TTM)

COYA12.29x

FHTX3.31x

Debt/Equity (TTM)

COYA0.00x

FHTX0.00x

Debt/Assets (TTM)

COYA0.0%

FHTX0.0%

Interest Coverage (TTM)

COYAN/A

FHTXN/A

Net Debt/EBITDA (TTM)

COYA0.00x

FHTX0.00x

Beta

COYA0.58

FHTX3.13

52W Performance

COYA-21.6%

FHTX-55.6%

YTD Performance

COYA-12.4%

FHTX-61.5%

% from 52W High

COYA-36.1%

FHTX-73.7%

% from 52W Low

COYA33.4%

FHTX11.7%

Asset Turnover (TTM)

COYA0.18x

FHTX0.18x

FCF Yield (TTM)

COYA-15.3%

FHTX-71.8%

Earnings Yield (TTM)

COYA-18.7%

FHTX-55.0%

Dividend Yield (TTM)

COYAN/A

FHTXN/A

Rule of 40

COYA1,571.9

FHTX-177.4

EV/GP/RG

COYAN/A

FHTXN/A

Ticker research

View COYA research View FHTX research

Metric	COYA Coya Therapeutics Inc	FHTX Foghorn Therapeutics Inc
Market & Valuation
Market Cap	$116M	$117M
Enterprise Value	$73M	$49M
Price	$4.95	$2.00
P/E Ratio	N/A	N/A
P/S Ratio	14.48x	3.20x
EV/Sales	9.10x	1.34x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.61x	1,199.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.10x	-0.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	35.49x	4.04x
Revenue & Growth
Revenue (TTM)	$8M	$37M
Revenue Growth (YoY)	1793.6%	52.0%
Forward Rev Growth	389.9%	7.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-259.8%	-180.6%
Net Margin (TTM)	-270.2%	-175.8%
FCF Margin (TTM)	-221.6%	-229.4%
Net Income (TTM)	$-22M	$-65M
FCF (TTM)	$-18M	$-84M
EPS (TTM)	-$0.92	-$0.91
ROE (TTM)	-5332.0%	-30161.0%
ROA (TTM)	-4748.0%	-3117.0%
ROIC (TTM)	-5332.0%	-30161.0%
Financial Health
Cash	$43M	$68M
Debt	$0	$0
Net Cash/Debt	$43M	$68M
Current Ratio (TTM)	13.40x	3.36x
Quick Ratio (TTM)	12.29x	3.31x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	3.13
52W Performance	-21.6%	-55.6%
YTD Performance	-12.4%	-61.5%
% from 52W High	-36.1%	-73.7%
% from 52W Low	33.4%	11.7%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.18x
FCF Yield (TTM)	-15.3%	-71.8%
Earnings Yield (TTM)	-18.7%	-55.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,571.9	-177.4
EV/GP/RG	N/A	N/A
Ticker research	View COYA research	View FHTX research

Valuation

P/S Ratio

FHTX

3.20x

COYA

14.48x

EV/FCF

COYA

-4.10x

FHTX

-0.59x

Growth & revenue

Revenue Growth TTM

COYA

1793.6%

FHTX

52.0%

Forward Revenue Growth

COYA

389.9%

FHTX

7.3%

Profitability & performance

Gross Margin

COYA

0.0%

FHTX

0.0%

ROE

COYA

-5332.0%

FHTX

-30161.0%

FCF Yield %

COYA

-15.3%

FHTX

-71.8%

52-Week Performance

COYA

-21.6%

FHTX

-55.6%

Detailed metrics comparison

COYA

Coya Therapeutics Inc

FHTX

Foghorn Therapeutics Inc

Market Cap

COYA$116M

FHTX$117M

Enterprise Value

COYA$73M

FHTX$49M

Price

COYA$4.95

FHTX$2.00

P/E Ratio

COYAN/A

FHTXN/A

P/S Ratio

COYA14.48x

FHTX3.20x

EV/Sales

COYA9.10x

FHTX1.34x

EV/EBITDA

COYA0.00x

FHTX0.00x

P/B Ratio

COYA2.61x

FHTX1,199.58x

P/FCF Ratio

COYAN/A

FHTXN/A

EV/FCF

COYA-4.10x

FHTX-0.59x

PEG Ratio

COYAN/A

FHTXN/A

Forward P/E (NTM)

COYAN/A

FHTXN/A

Forward P/S (NTM)

COYA35.49x

FHTX4.04x

Revenue (TTM)

COYA$8M

FHTX$37M

Revenue Growth (YoY)

COYA1793.6%

FHTX52.0%

Forward Rev Growth

COYA389.9%

FHTX7.3%

Gross Margin (TTM)

COYA0.0%

FHTX0.0%

Operating Margin (TTM)

COYA0.0%

FHTX0.0%

EBITDA Margin (TTM)

COYA-259.8%

FHTX-180.6%

Net Margin (TTM)

COYA-270.2%

FHTX-175.8%

FCF Margin (TTM)

COYA-221.6%

FHTX-229.4%

Net Income (TTM)

COYA$-22M

FHTX$-65M

FCF (TTM)

COYA$-18M

FHTX$-84M

EPS (TTM)

COYA-$0.92

FHTX-$0.91

ROE (TTM)

COYA-5332.0%

FHTX-30161.0%

ROA (TTM)

COYA-4748.0%

FHTX-3117.0%

ROIC (TTM)

COYA-5332.0%

FHTX-30161.0%

Cash

COYA$43M

FHTX$68M

Debt

COYA$0

FHTX$0

Net Cash/Debt

COYA$43M

FHTX$68M

Current Ratio (TTM)

COYA13.40x

FHTX3.36x

Quick Ratio (TTM)

COYA12.29x

FHTX3.31x

Debt/Equity (TTM)

COYA0.00x

FHTX0.00x

Debt/Assets (TTM)

COYA0.0%

FHTX0.0%

Interest Coverage (TTM)

COYAN/A

FHTXN/A

Net Debt/EBITDA (TTM)

COYA0.00x

FHTX0.00x

Beta

COYA0.58

FHTX3.13

52W Performance

COYA-21.6%

FHTX-55.6%

YTD Performance

COYA-12.4%

FHTX-61.5%

% from 52W High

COYA-36.1%

FHTX-73.7%

% from 52W Low

COYA33.4%

FHTX11.7%

Asset Turnover (TTM)

COYA0.18x

FHTX0.18x

FCF Yield (TTM)

COYA-15.3%

FHTX-71.8%

Earnings Yield (TTM)

COYA-18.7%

FHTX-55.0%

Dividend Yield (TTM)

COYAN/A

FHTXN/A

Rule of 40

COYA1,571.9

FHTX-177.4

EV/GP/RG

COYAN/A

FHTXN/A

Ticker research

View COYA research View FHTX research

Metric	COYA Coya Therapeutics Inc	FHTX Foghorn Therapeutics Inc
Market & Valuation
Market Cap	$116M	$117M
Enterprise Value	$73M	$49M
Price	$4.95	$2.00
P/E Ratio	N/A	N/A
P/S Ratio	14.48x	3.20x
EV/Sales	9.10x	1.34x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.61x	1,199.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.10x	-0.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	35.49x	4.04x
Revenue & Growth
Revenue (TTM)	$8M	$37M
Revenue Growth (YoY)	1793.6%	52.0%
Forward Rev Growth	389.9%	7.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-259.8%	-180.6%
Net Margin (TTM)	-270.2%	-175.8%
FCF Margin (TTM)	-221.6%	-229.4%
Net Income (TTM)	$-22M	$-65M
FCF (TTM)	$-18M	$-84M
EPS (TTM)	-$0.92	-$0.91
ROE (TTM)	-5332.0%	-30161.0%
ROA (TTM)	-4748.0%	-3117.0%
ROIC (TTM)	-5332.0%	-30161.0%
Financial Health
Cash	$43M	$68M
Debt	$0	$0
Net Cash/Debt	$43M	$68M
Current Ratio (TTM)	13.40x	3.36x
Quick Ratio (TTM)	12.29x	3.31x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	3.13
52W Performance	-21.6%	-55.6%
YTD Performance	-12.4%	-61.5%
% from 52W High	-36.1%	-73.7%
% from 52W Low	33.4%	11.7%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.18x
FCF Yield (TTM)	-15.3%	-71.8%
Earnings Yield (TTM)	-18.7%	-55.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,571.9	-177.4
EV/GP/RG	N/A	N/A
Ticker research	View COYA research	View FHTX research